Literature DB >> 34035665

Serum antibody response in COVID-19-recovered patients who retested positive.

Nicole Atchessi1, Megan Striha1, Rojiemiahd Edjoc1, Christine Abalos1, Amanda Lien1, Lisa Waddell2, Imran Gabrani-Juma1, Emily Thompson1, Thomas Dawson1.   

Abstract

BACKGROUND: Research studies comparing antibody response from coronavirus disease 2019 (COVID-19) cases that retested positive (RP) using reverse transcription polymerase chain reaction (RT-PCR) and those who did not retest positive (NRP) were used to investigate a possible relationship between antibody response and retesting status.
METHODS: Seven data bases were searched. Research criteria included cohort and case-control studies, carried out worldwide and published before September 9, 2020, that compared the serum antibody levels of hospitalized COVID-19 cases that RP after discharge to those that did NRP.
RESULTS: There is some evidence that immunoglobulin G (IgG) and immunoglobulin M (IgM) antibody levels in RP cases were lower compared with NRP cases. The hypothesis of incomplete clearance aligns with these findings. The possibility of false negative reverse transcription polymerase chain reaction (RT-PCR test results during viral clearance is also plausible, as concentration of the viral ribonucleic acid (RNA) in nasopharyngeal and fecal swabs fluctuate below the limits of RT-PCR detection during virus clearance. The probability of reinfection was less likely to be the cause of retesting positive because of the low risk of exposure where cases observed a 14 day-quarantine after discharge.
CONCLUSION: More studies are needed to better explain the immune response of recovered COVID-19 cases retesting positive after discharge.

Entities:  

Keywords:  COVID-19; RT-PCR; SARS-CoV-2; false-negative; reinfection; retesting

Year:  2021        PMID: 34035665      PMCID: PMC8127687          DOI: 10.14745/ccdr.v47i04a03

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  10 in total

1.  The Issue of Recurrently Positive Patients Who Recovered From COVID-19 According to the Current Discharge Criteria: Investigation of Patients from Multiple Medical Institutions in Wuhan, China.

Authors:  You Zou; Bin-Ru Wang; Liu Sun; Shan Xu; Yong-Gang Kong; Li-Jun Shen; Geng-Tian Liang; Shi-Ming Chen
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

2.  Positive RT-PCR Test Results in Patients Recovered From COVID-19.

Authors:  Lan Lan; Dan Xu; Guangming Ye; Chen Xia; Shaokang Wang; Yirong Li; Haibo Xu
Journal:  JAMA       Date:  2020-04-21       Impact factor: 56.272

3.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

4.  Clinical features of COVID-19 convalescent patients with re-positive nucleic acid detection.

Authors:  Hui Zhu; Liyun Fu; Yinhua Jin; Jiale Shao; Shun Zhang; Nanhong Zheng; Lingyan Fan; Zhe Yu; Jun Ying; Yaoren Hu; Tongen Chen; Yanglingzi Chen; Min Chen; Mingjue Chen; Zi Xiong; Junfei Kang; Jiachang Jin; Ting Cai; Honghua Ye
Journal:  J Clin Lab Anal       Date:  2020-06-07       Impact factor: 2.352

5.  Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation.

Authors:  Bo Yuan; Han-Qing Liu; Zheng-Rong Yang; Yong-Xin Chen; Zhi-Yong Liu; Kai Zhang; Cheng Wang; Wei-Xin Li; Ya-Wen An; Jian-Chun Wang; Shuo Song
Journal:  Sci Rep       Date:  2020-07-17       Impact factor: 4.379

6.  Diagnostic Performance of CT and Reverse Transcriptase Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis.

Authors:  Hyungjin Kim; Hyunsook Hong; Soon Ho Yoon
Journal:  Radiology       Date:  2020-04-17       Impact factor: 11.105

7.  Recurrent positive SARS-CoV-2: Immune certificate may not be valid.

Authors:  Tao Liu; Sanyun Wu; Guang Zeng; Fuling Zhou; Yirong Li; Fangjian Guo; Xinghuan Wang
Journal:  J Med Virol       Date:  2020-06-09       Impact factor: 20.693

8.  Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study.

Authors:  Chao Yang; Min Jiang; Xiaohui Wang; Xiujuan Tang; Shisong Fang; Hao Li; Le Zuo; Yixiang Jiang; Yifan Zhong; Qiongcheng Chen; Chenli Zheng; Lei Wang; Shuang Wu; Weihua Wu; Hui Liu; Jing Yuan; Xuejiao Liao; Zhen Zhang; Xiaolu Shi; Yijie Geng; Huan Zhang; Huanying Zheng; Min Wan; Linying Lu; Xiaohu Ren; Yujun Cui; Xuan Zou; Tiejian Feng; Junjie Xia; Ruifu Yang; Yingxia Liu; Shujiang Mei; Baisheng Li; Zhengrong Yang; Qinghua Hu
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

9.  Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR.

Authors:  Jing Lu; Jinju Peng; Qianling Xiong; Zhe Liu; Huifang Lin; Xiaohua Tan; Min Kang; Runyu Yuan; Lilian Zeng; Pingping Zhou; Chumin Liang; Lina Yi; Louis du Plessis; Tie Song; Wenjun Ma; Jiufeng Sun; Oliver G Pybus; Changwen Ke
Journal:  EBioMedicine       Date:  2020-08-24       Impact factor: 8.143

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.